Clinical Trial

Vertebral Augmentation and Percutaneous Fixation for Thoracolumbar Burst Fractures Requiring Corpectomy

Study acronym: EXVERCOR
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 12, 2026 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study evaluates minimally invasive vertebral augmentation combined with percutaneous fixation for the treatment of severe thoracolumbar burst fractures. Traditionally, fractures with a Load Sharing Classification (LSC) score ≥7 require corpectomy, which is associated with significant morbidity. Newer techniques, such as vertebral expansion devices, may restore vertebral height and alignment while reducing the need for invasive anterior procedures. This study aims to assess their effectiveness in this population.
Trial Details
NCT Number NCT07645092
Lead Sponsor University Hospital, Grenoble
Conditions Thoracolumbar Burst Fractures
Enrollment 30 participants
Start Date 2026-06-15
Primary Completion 2026-06-15 (estimated)
Study Completion 2027-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-12